IYH News and Press, iShares U.S. Healthcare From 01/14/24

2024-01-14 03:40:00 ET Summary Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharma will be acquired by Johnson & Johnson for $2 billion. GSK plans to acquire Aiolos Bio, a San Francisco-London s...

2024-01-12 11:27:00 ET Summary Horiba is likely undervalued due to it being under followed, and offers a rare combination of a quality business at an attractive price. The company has high market share in specialized devices in various industries, including automotive, process &am...

2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...

2024-01-07 04:45:00 ET Summary Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Suzhou MediLink Therapeutics out-licensed global rights for its pre-clinical c-Mesenchymal epithelial transition factor ADC to R...

2024-01-06 08:15:00 ET Summary Global equity markets experienced a surge in 2023 driven by economic growth and investor confidence. US equity returns exceeded expectations despite concerns about higher rates, inflation, and geopolitical tension. In 2024, investors should focus...

2023-12-28 02:46:47 ET Summary iShares U.S. Healthcare ETF provides exposure to the healthcare sector, holding 120 healthcare-related stocks. Healthcare stocks have had varying performances in recent years, with winners and losers in the sector. The increasing prevalence of ch...

2023-12-21 15:49:22 ET More on iShares U.S. Healthcare ETF IYH: Long-Term Growth Outlook Not As Bright As Before Seeking Alpha’s Quant Rating on iShares U.S. Healthcare ETF Dividend scorecard for iShares U.S. Healthcare ETF For further details see: ...

BlackRock, Inc. (NYSE: BLK) today announced its plans to implement stock splits for the ETFs listed below. These splits will lower the share price and increase the number of outstanding shares. The total value of shares outstanding is not affected by the share split. For the iShares Core S&am...

2023-12-21 08:25:00 ET Summary Given strong recent market returns and another wave of capital inflows, the backdrop is probably not enough to lead to strong tactical performance from risk assets. The US has a more favorable demographic trend; its working-age population is expected...

2023-12-20 06:19:00 ET Summary Can the Magnificent 7 continue to rally into 2024? How the Magnificent 7's rise compares to the dot-com bubble. Why the rise in tech stocks highlights shortcomings for the markets. The rise of the Magnificent 7 tech stocks has been a ke...